• Clinics in Shoulder and Elbow
• /
• 제20권4호
• /
• pp.222-229
• /
• 2017

Background: The purpose of this study was to investigate the outcomes after fixation using a 3.5-mm locking compression plate (LCP) hook plate for isolated greater tuberosity (GT) fractures of the proximal humerus. Methods: We evaluated the postoperative radiological and clinical outcomes in nine patients who were followed up at least 1 year with isolated GT fractures. Using the deltopectoral approach, we fixed the displaced GT fragments with a 3.5-mm LCP hook plate (Synthes, West Chester, PA, USA). Depending on the fracture patterns, the hook plate was fixed with or without augmentation using either tension suture or suture anchor fixation. Results: All the patient showed successful bone union. The mean time-to-union was 11 weeks. The radiological and clinical outcomes at the final follow-up were generally satisfactory. The mean visual analogue scale for pain, the University of California at Los Angeles score, the American Shoulder and Elbow Surgeons score, and the subjective shoulder value were 1.4, 30.3, 84.3, and 82.2%, respectively. The mean active forward flexion, abduction, external rotation, and internal rotation of the shoulder were $156.7^{\circ}$, $152.2^{\circ}$, $61.1^{\circ}$, and the 10th thoracic vertebral level, respectively. Only one patient presented with a postoperative complication of shoulder stiffness. The patient was treated through arthroscopic capsular release on the 5th postoperative month. Conclusions: We conclude that fixation using 3.5-mm LCP hook plates for isolated GT fractures of the proximal humerus is a useful treatment method that provides satisfactory clinical and radiological outcomes.

• Clinics in Shoulder and Elbow
• /
• 제16권2호
• /
• pp.107-114
• /
• 2013

목적: 상완골 간부 골절에서 골수강 내 금속정 고정을 시행한 후 잔존한 전위에 대해 임상적, 방사선학적 결과를 분석하였다. 대상 및 방법: 2004년 7월부터 2011년 8월까지 상완골 간부 골절에 대해서 골수강 내 금속정 고정 후 잔존한 전위가 10 mm 이상, 20 mm 미만인 8예를 대상으로 하였다. 평균 연령은 54.1세(43~70세), 남자 3예, 여자 5예였다. 수술 직후 단순 방사선 사진으로 전위와 각형성의 정도를 측정하였으며, 추시 방사선 사진으로 이의 호전 정도와 골유합, 합병증 여부를 확인하였다. 술 후 견관절 및 주관절의 운동 범위와 통증에 대해서 조사하였다. 결과: 모든 예에서 골유합을 얻을 수 있었고, 평균 골유합 기간은 16.1주였다. 최종 추시 견관절 및 주관절의 운동범위는 대부분 정상 범위로 돌아왔다. 1예에서 견관절 강직으로 인하여 관절경적 관절낭 이완술 및 도수 조작술 후 운동범위를 회복하였으며, 일시적인 견관절 통증 1예, 주관절 통증 1예가 있었다. 2예에서 근위 나사못의 빠짐이 있었으나 모두 골유합을 얻었다. 결론: 상완골 간부 골절에서 골수강 내 금속정 고정 후 잔존한 전위에도 불구하고 골유합을 얻을 수 있었으며 우수한 임상적 결과를 보였기 때문에, 관혈적 정복 또는 추가 고정은 필요하지 않았다.

• 대한약침학회지
• /
• 제27권1호
• /
• pp.14-20
• /
• 2024

Objectives: Frozen shoulder (FS) is one of the most challenging shoulder disorders for patients and clinicians. Its symptoms mainly include any combination of stiffness, nocturnal pain, and limitation of active and passive glenohumeral joint movement. Conventional treatment options for FS are physical therapy, nonsteroidal anti-inflammatory drugs, injection therapy, and arthroscopic capsular release, but adverse and limited effects continue to present problems. As a result, pharmacoacupuncture (PA) is getting attention as an alternative therapy for patients with FS. PA is a new form of acupuncture treatment in traditional Korean medicine (TKM) that is mainly used for musculoskeletal diseases. It has similarity and specificity compared to corticosteroid injection and hydrodilatation, making it a potential alternative injection therapy for FS. However, no systematic reviews investigating the utilization of PA for FS have been published. Therefore, this review aims to standardize the clinical use of PA for FS and validate its therapeutic effect. Methods: The protocol was registered in Prospero (CRD42023445708) on 18 July 2023. Until Aug. 31, 2023, seven electronic databases will be searched for randomized controlled trials of PA for FS. Authors will be contacted, and manual searches will also be performed. Two reviewers will independently screen and collect data from retrieved articles according to predefined criteria. The primary outcome will be pain intensity, and secondary outcomes will be effective rate, Constant-Murley Score, Shoulder Pain and Disability Index, range of motion, quality of life, and adverse events. Bias and quality of the included trials will be assessed using the Cochrane handbook's risk-of-bias tool for randomized trials. Meta analyses will be conducted using Review Manager V.5.3 software. GRADE will be used to evaluate the level of evidence for each outcome. Results: This systematic review and meta-analysis will be conducted following PRISMA statement. The results will be published in a peer-reviewed journal. Conclusion: This review will provide scientific evidence to support health insurance policy as well as the standardization of PA in clinical practice.